A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease

Published:2016-04-05 Issue:1 Volume:64 Page:85-91
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Klair Jagpal Singh¹,Yang Ju Dong²,Abdelmalek Manal F.³,Guy Cynthia D.⁴,Gill Ryan M.⁵,Yates Katherine⁶,Unalp-Arida Aynur⁷,Lavine Joel E.⁸,Clark Jeanne M.⁹¹⁰,Diehl Anna Mae³,Suzuki Ayako³¹¹¹²,

Affiliation:

1. Department of Medicine; University of Arkansas for Medical Sciences; Little Rock AR

2. Division of Gastroenterology and Hepatology; Mayo Clinic College of Medicine; Rochester MN

3. Gastroenterology and Hepatology; Duke University; Durham NC

4. Department of Pathology; Duke University; Durham NC

5. Department of Pathology; University of California San Francisco; San Francisco CA

6. Nonalcoholic Steatohepatitis Clinical Research Network Data Coordinating Center; Johns Hopkins Bloomberg School of Public Health; Baltimore MD

7. Division of Digestive Diseases and Nutrition; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Bethesda MD

8. Department of Pediatrics; Columbia University; New York NY

9. Division of General Internal Medicine; Department of Medicine; The Johns Hopkins School of Medicine

10. Department of Epidemiology; The Johns Hopkins Bloomberg School of Public Health; Baltimore MD

11. Gastroenterology; Central Arkansas Veterans Healthcare System

12. Gastroenterology and Hepatology; University of Arkansas for Medical Sciences; Little Rock AR

Funder

National Center for Advancing Translational Sciences

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28514/fullpdf

Reference14 articles.

1. Nonalcoholic fatty liver disease in women;Suzuki;Womens Health (Lond Engl),2009

2. Nonalcoholic fatty liver disease;Clark;Gastroenterology,2002

3. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis;Yang;Hepatology,2014

4. The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease;Yoneda;Hepatology,2014

5. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats;Yasuda;Hepatology,1999

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The deleterious effects and potential therapeutic strategy of fluorene-9-bisphenol on circadian activity and liver diseases in zebrafish and mice;Journal of Environmental Sciences;2024-11

2. Metabolic dysfunction associated steatotic liver disease: Current practice, screening guidelines and management in the primary care setting;The American Journal of the Medical Sciences;2024-02

3. Association of hysterectomy with nonalcoholic fatty liver disease among US women;Lipids in Health and Disease;2024-01-31

4. Sex-specific differences in ectopic fat and metabolic characteristics of paediatric nonalcoholic fatty liver disease;International Journal of Obesity;2023-12-20

5. 17β-Estradiol (E2) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD);Antioxidants;2023-12-12